Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DarbeRel
- Development stage
- Unknown
- Lead developer
- Reliance Life Sciences
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous, Subcutaneous
01
Overview
DarbeRel is a recombinant glycoprotein biologic developed and marketed by Reliance Life Sciences. It is a biosimilar of darbepoetin alfa, an erythropoiesis-stimulating agent (ESA). The drug functions as an erythropoietin (EPO) analog that binds to and activates the erythropoietin receptor on erythroid progenitor cells in the bone marrow, thereby stimulating the production of red blood cells. DarbeRel is indicated for the treatment of anemia associated with chronic kidney disease (CKD) in both adult and pediatric patients, including those on dialysis and those not on dialysis. It is also used to treat chemotherapy-induced anemia in adult patients with non-myeloid malignancies. It is administered via intravenous or subcutaneous injection and is available as pre-filled syringes.
- Brand names
- DarbeRel
- Other names
- darbepoetin alfa
02
Targets
Erythropoietin Receptor
Beyond the preview
Go deeper on DarbeRel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DarbeRel.